[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 3,591
Citations 0
In This Issue of JAMA
September 25, 2013


JAMA. 2013;310(12):1203-1205. doi:10.1001/jama.2013.5325

In a randomized clinical trial that enrolled 95 children and adults with type 1 diabetes mellitus and impaired hypoglycemic awareness, Ly and colleagues investigated the effect of sensor-augmented insulin pump therapy with an automated insulin suspension function on the incidence of major hypoglycemic events. The authors report that compared with standard insulin pump therapy, sensor-augmented insulin pump therapy with automated insulin suspension—for up to 2 hours when patients did not respond to a low glucose alarm—reduced the rate of severe and moderate hypoglycemic events. In an Editorial, Choudhary discusses the potential of sensor-augmented insulin pump therapy with a threshold-suspension function to reduce episodes of nocturnal hypoglycemia.